Interestingly we also report a second ESR1 D538G mutation at 32% cancer cell fraction (CCF) in Ovary Met R2, indicating that strong selective pressures and consequent convergent evolution for ESR1 mutants. This evidence concerns the gene ESR1 and cancer.